Mb, Levis & Associates, Llc
Source: SEC Form 13F · as of Mar 2026Mb, Levis & Associates, Llc holds 20 biotech & pharma companies tracked by BioSniper, totaling $8.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$8.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 10,689 | $2.6M |
| ABTABBOTT LABORATORIES | 15,488 | $1.6M |
| MRKMerck & Co., Inc. | 11,772 | $1.4M |
| AMGNAMGEN INC | 2,956 | $1.0M |
| NVSNovartis AG | 5,410 | $826K |
| ABBVAbbVie Inc. | 547 | $119K |
| LLYELI LILLY & Co | 125 | $115K |
| PFEPFIZER INC | 3,773 | $106K |
| PMPhilip Morris International Inc | 598 | $99K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 302 | $82K |
| BMYBRISTOL MYERS SQUIBB CO | 1,101 | $67K |
| IMNMImmunome Inc. | 2,373 | $52K |
| FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) | 478 | $11K |
| ZTSZoetis Inc. | 25 | $3K |
| PGNYProgyny Inc. | 100 | $2K |
| OGNOrganon & Co. | 201 | $1K |
| CRONCronos Group Inc. | 330 | $828 |
| VTRSViatris Inc | 48 | $654 |
| VYNEVYNE Therapeutics Inc. | 1,041 | $622 |
| KPTIKaryopharm Therapeutics Inc. | 100 | $557 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.